Results 121 to 130 of about 53,618 (254)

Low Weight Loss Response to Incretin Analogs: A Systematic Review

Obesity Reviews, EarlyView.
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley   +1 more source

The Role of Antioxidants in the Management of Polycystic Ovary Syndrome. [PDF]

Antioxidants (Basel)
Sorić T, Matek Sarić M, Herceg Romanić S, Sarić A, Jonjić A, Čoklo M.   +5 more
europepmc   +1 more source

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Obesity Reviews, EarlyView.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani, Tzu‐Wen L. Cross, Erica de Jong, Emily S. Glover, Ivan D. Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D. Mattes   +8 more
wiley   +1 more source

Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome. [PDF]

Endocr Connect
Trzcinski M, Chudzicka-Strugala I, Kim K, Piekarski P, Spaczynski R, Zwoździak B, Banaszewska B, Pawelczyk L, Chang RJ, Duleba AJ.   +9 more
europepmc   +1 more source

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Obesity Reviews, EarlyView.
ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Angela C. Flynn, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger   +19 more
wiley   +1 more source

The stromal microenvironment of ovary: a novel area in polycystic ovary syndrome. [PDF]

J Ovarian Res
Wang H, Zhou H, Liu Z, Zhao T, Zhang C.
europepmc   +1 more source

Summarizing the Experiences of Individuals Who Have Obesity or Larger Bodies Seeking Fertility Care: A Scoping Review

Obesity Reviews, EarlyView.
ABSTRACT Females who have larger bodies or obesity may be at an increased risk for experiencing infertility. Problematically, both weight or body size and infertility are stigmatized, harming quality of care. We conducted a scoping review to understand the lived experiences of patients who may be subjected to intersecting stigmas of weight and ...
Brooke J. Hebert, Hanna Randhawa, Virginie Blanchette, Kristi B. Adamo, Angela Alberga, Jean‐Patrice Baillargeon, Marilou Côté, Julia Craig, Ariadne Daniel, Liz Dennett, Nicola Heslehurst, Sarah Nutter, Ian Patton, Helena Piccinini‐Vallis, Ximena Ramos Salas, Katie Wadden, Taniya S. Nagpal   +16 more
wiley   +1 more source

The impact of daily steps on polycystic ovary syndrome patients. [PDF]

Front Endocrinol (Lausanne)
Wang T, Zhang L, Ma L, Luo X, Li C.
europepmc   +1 more source

Critical Windows of Air Pollution Exposure During Spermatogenesis and Intrauterine Insemination Outcomes

Paediatric and Perinatal Epidemiology, EarlyView.
ABSTRACT Background Male preconception health remains a critically under‐addressed area of family planning. While research suggests air pollution may harm semen quality, downstream impacts on pregnancy, particularly for more vulnerable infertility treatment populations, are understudied.
Lindsey M. Russo, J. Richard Pilsner, Timothy P. Canty, Neil J. Perkins, Pauline Mendola, Karen C. Schliep, May Shaaban, Rachael B. Hemmert, Akanksha Singh, Allison M. Ring, James A. Vanderslice, C. Matthew Peterson, Erica B. Johnstone, Kaniz Rabeya, Carrie Nobles   +14 more
wiley   +1 more source

Pentraxin 3 levels in polycystic ovary syndrome: a meta-analysis. [PDF]

J Ovarian Res
Mohammadpour Fard R, Nadi M, Mansouri Z, Kazemzadeh R, Radmehr V, Hosseinpour M, Sakhavarz T, Bahreiny SS.   +7 more
europepmc   +1 more source